Vitamin D and osteoporosis in HIV/HCV coinfected patients: A literature review

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Di Carlo, Paola ^a   Siracusa, Lucia ^a   Mazzola, Giovanni ^a   Colletti, Piero ^a   Soresi, Maurizio ^a   Giannitrapani, Lydia ^a   Li Vecchi, Valentina ^a   Montalto, Giuseppe ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

AGE; DISEASE ASSOCIATION; DISEASE COURSE; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LIVER FIBROSIS; MIXED INFECTION; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84939182111     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/969040     Document Type: Review

References (49)

1. L. Langsetmo, C. Berger, N. Kreiger et al. , "CalciumandVitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos), " Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 7, pp. 3010-3018, 2013.
2. V. A. Moyer, "Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U. S. Preventive services Task Force recommendation statement, " Annals of InternalMedicine, vol. 160, no. 8, pp. 558-564, 2014.
3. D. A. Hanley, A. Cranney, G. Jones et al. , "Guidelines committee of the scientific advisory council of osteoporosis canada, " CanadianMedical Association Journal, vol. 182, no. 12, pp. E610-E618, 2010.
4. M. Hewison, "Vitamin D and immune function: an overview, " Proceedings of theNutrition Society, vol. 71, no. 1, pp. 50-61, 2012.
5. S. Roy, K. Shrinivas, and B. Bagchi, "A stochastic chemical dynamic approach to correlate autoimmunity and optimal vitamin-D range, " PLoS ONE, vol. 9, no. 6, Article ID e100635, 2014.
6. P. E. Pfeffer, E. H. Mann, E. Hornsby et al. , "Vitamin D influences asthmatic pathology through its action on diverse immunological pathways, " Annals of the American Thoracic Society, vol. 11, supplement 5, pp. S314-S321, 2014.
7. P. Iruzubieta, Á. Terán, J. Crespo, and E. Fábrega, "Vitamin D deficiency in chronic liver disease, " World Journal of Hepatology, vol. 6, no. 12, pp. 901-915, 2014.
8. Y. -Q. Luo, X. -X. Wu, Z. -X. Ling, Y. -W. Cheng, L. Yuan, and C. Xiang, "Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic metaanalysis, " Journal of Zhejiang University SCIENCE B, vol. 15, no. 10, pp. 900-906, 2014.
9. S. Petta, S. Grimaudo, V. D. Marco et al. , "Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients, " Journal of Viral Hepatitis, vol. 20, no. 7, pp. 486-493, 2013.
10. B. Terrier, F. Carrat, G. Geri et al. , "Low25-OHvitaminDserum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis, " Journal of Hepatology, vol. 55, no. 4, pp. 756-761, 2011.
11. S. Abu-Mouch, Z. Fireman, J. Jarchovsky, A. -R. Zeina, and N. Assy, "Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-näive patients, " World Journal of Gastroenterology, vol. 17, no. 47, pp. 5184-5190, 2011.
12. S. Petta, S. Grimaudo, C. Tripodo et al. , "The hepatic expression of vitamin d receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients, " The Journal of Clinical Endocrinology &Metabolism, vol. 100, no. 1, pp. 193-200, 2015.
13. M. Gal-Tanamy, L. Bachmetov, A. Ravid et al. , "Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes, " Hepatology, vol. 54, no. 5, pp. 1570-1579, 2011.
14. D. Bitetto, C. Fabris, E. Fornasiere et al. , "VitaminDsupplementation improves response to antiviral treatment for recurrent hepatitis C, " Transplant International, vol. 24, no. 1, pp. 43-50, 2011.
15. J. K. Rockstroh, A. Mocroft, V. Soriano et al. , "Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy, " Journal of Infectious Diseases, vol. 192, no. 6, pp. 992-1002, 2005.
16. K. E. Sherman, S. D. Rouster, R. T. Chung, and N. Rajicic, "Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group, " Clinical Infectious Diseases, vol. 34, no. 6, pp. 831-837, 2002.
17. C. T. Staples Jr. , D. Rimland, and D. Dudas, "Hepatitis C in the HIV (Human Immunodeficiency Virus) Atlanta V. A. (Veterans Affairs Medical Center) cohort study (HAVACS): the effect of coinfection on survival, " Clinical Infectious Diseases, vol. 29, no. 1, pp. 150-154, 1999.
18. A. Bonjoch, M. Figueras, C. Estany et al. , "Osteoporosis Study Group. High prevalence of and progression to low bonemineral density in HIV-infected patients: a longitudinal cohortstudy, " AIDS, vol. 24, no. 18, pp. 2827-2833, 2010.
19. V. A. Triant, T. T. Brown, H. Lee, and S. K. Grinspoon, "Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U. S. healthcare system, " The Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 9, pp. 3499-3504, 2008.
20. A. F. Luetkemeyer, D. V. Havlir, and J. S. Currier, "CROI 2013: complications of HIV disease, viral hepatitis, and antiretroviral therapy, " Topics in Antiviral Medicine, vol. 21, no. 2, pp. 62-74, 2013.
21. N. M. Maalouf, S. Zhang, H. Drechsler, G. R. Brown, P. Tebas, and R. Bedimo, "Hepatitis C Co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIVinfected patients, " Journal of Bone andMineral Research, vol. 28, no. 12, pp. 2577-2583, 2013.
22. H. V. Dong, Y. I. Cortés, S. Shiau, and M. T. Yin, "Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis, " AIDS, vol. 28, no. 14, pp. 2119-2131, 2014.
23. C. Zhou, M. Assem, J. C. Tay et al. , "Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia, " The Journal of Clinical Investigation, vol. 116, no. 6, pp. 1703-1712, 2006.
24. M. F. Holick, N. C. Binkley, H. A. Bischoff-Ferrari et al. , "Evaluation, treatment, and prevention of vitaminDdeficiency: an endocrine society clinical practice guideline, " The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 7, pp. 1911-1930, 2011.
25. E. Ramayo, M. P. González-Moreno, J. Macías et al. , "Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy, " AIDS Research and Human Retroviruses, vol. 21, no. 11, pp. 915-921, 2005.
26. K. Gyllensten, F. Josephson, K. Lidman, and M. Sääf, "Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59 degrees, " AIDS, vol. 20, no. 14, pp. 1906-1907, 2006.
27. K. Childs, C. Kadish, W. Branch-Elliman, S. Fishman, M. Mullen, and A. Branch, "Vitamin D and calcium supplements reverse the secondary hyperparathyroidism that commonly occurs in HIV patients on TDF containingHAART, " in Proceedings of the 15th Annual Conference of the BritishHIV Association, vol. 10, p. 40, HIV Medication, Liverpool, UK, 2009, Abstract P89.
28. P. Rivas, M. Górgolas, R. García-Delgado, M. Díaz-Curiel, A. Goyenechea, and M. L. Fernández-Guerrero, "Evolution of bone mineral density in AIDS patients on treatment with zidovudine/ lamivudine plus abacavir or lopinavir/ritonavir, " HIV Medicine, vol. 9, no. 2, pp. 89-95, 2008.
29. P. L. Havens, K. Mulligan, R. Hazra et al. , "Serum25-hydroxyvitamin D response to vitamin D3 supplementation 50, 000 IU monthly in youth with HIV-1 infection, " Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 11, pp. 4004-4013, 2012.
30. V. W. Harris and T. T. Brown, "Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies, " The Journal of Infectious Diseases, vol. 205, no. 3, pp. S391-S398, 2012.
31. M. Guzmán-Fulgencio, M. García-Álvarez, J. Berenguer et al. , "VitaminDdeficiency is associated with severity of liver disease in HIV/HCV coinfected patients, " Journal of Infection, vol. 68, no. 2, pp. 176-184, 2014.
32. A. Avihingsanon, S. Jitmitraparp, P. Tangkijvanich et al. , "Advanced liver fibrosis by transient elastography, Fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels, " Journal of Gastroenterology and Hepatology, vol. 29, no. 9, pp. 1706-1714, 2014.
33. D. El-Maouche, S. H. Mehta, C. G. Sutcliffe et al. , "Vitamin D deficiency and its relation to bone mineral density and liver fibrosis inHIV-HCVcoinfection, " AntiviralTherapy, vol. 18, no. 2, pp. 237-242, 2013.
34. M. Mandorfer, B. A. Payer, P. Schwabl et al. , "Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3, " Liver International, vol. 35, no. 3, pp. 876-885, 2015.
35. M. Mandorfer, T. Reiberger, B. A. Payer et al. , "Low vitamin D levels are associated with impaired virologic response to PEGIFN+RBV therapy in HIV-hepatitis C virus coinfected patients, " AIDS, vol. 27, no. 2, pp. 227-232, 2013.
36. A. D. Branch, M. Kang, K. Hollabaugh, C. M. Wyatt, R. T. Chung, and M. J. Glesby, "In HIV/hepatitis C virus coinfected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use, " The American Journal of Clinical Nutrition, vol. 98, no. 2, pp. 423-429, 2013.
37. S. Linari, G. Montorzi, D. Bartolozzi et al. , "Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: a study in HCV/HIV or HCV infected patients, " Haemophilia, vol. 19, no. 1, pp. 126-133, 2013.
38. V. L. Vecchi, M. Soresi, L. Giannitrapani et al. , "Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects, " BMC Infectious Diseases, vol. 12, article 192, 2012.
39. L. Milazzo, C. Mazzali, G. Bestetti et al. , "Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population, " Current HIV Research, vol. 9, no. 3, pp. 186-193, 2011.
40. M. F. Holick, N. C. Binkley, H. A. Bischoff-Ferrari et al. , "Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited, " Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 4, pp. 1153-1158, 2012.
41. F. Cosman, D. C. Morgan, J. W. Nieves et al. , "Resistance to bone resorbing effects of PTH in black women, " Journal of Bone and Mineral Research, vol. 12, no. 6, pp. 958-966, 1997.
42. G. B. Taksler, D. M. Cutler, E. Giovannucci, and N. L. Keating, "Vitamin D deficiency in minority populations, " Public Health Nutrition, vol. 15, pp. 1-13, 2014.
43. P. Pludowski, W. B. Grant, H. P. Bhattoa et al. , "Vitamin D status in central Europe, " International Journal of Endocrinology, vol. 2014, Article ID 589587, 12 pages, 2014.
44. M. F. Holick and C. M. Gordon, "The hormone foundations: patient guide to vitamin D deficiency, " The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 7, pp. 1-2, 2011.
45. J. F. Calderon-Garcia, J. M. Moran, R. Roncero-Martin, P. Rey-Sanchez, F. J. Rodriguez-Velasco, and J. D. Pedrera-Zamorano, "Dietary habits, nutrients and bone mass in Spanish premenopausal women: the contribution of fish to better bone health, " Nutrients, vol. 5, no. 1, pp. 10-22, 2012.
46. M. Costa Silva, T. Erotides Silva, M. L. Alentar et al. , "Factors associated with 25-hydroxyvitamin D levels in patients with liver cirrhosis, " Annals of Hepatology, vol. 14, no. 1, pp. 99-107, 2015.
47. J. L. González-Calvin, J. L. Mundi, F. J. Casado-Caballero, A. C. Abadia, and J. J. Martin-Ibañez, "Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis, " The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 12, pp. 4844-4850, 2009.
48. M. P. Björkman, A. J. Sorva, J. Risteli, and R. S. Tilvis, "Low parathyroid hormone levels in bedridden geriatric patients with vitamin D deficiency, " Journal of the American Geriatrics Society, vol. 57, no. 6, pp. 1045-1050, 2009.
49. V. A. Stallings, J. I. Schall, M. L. Hediger et al. , "High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial, " The Pediatric Infectious Disease Journal. In press.